Search for: "Lynn Jokela"
Results 101 - 120
of 172
Sorted by Relevance
|
Sort by Date
15 May 2020, 3:03 am
A little more time for companies to think over whether to return the funds … – Lynn Jokela [read post]
2 Mar 2021, 3:03 am
– Lynn Jokela [read post]
24 Mar 2021, 3:03 am
– Lynn Jokela [read post]
22 Jun 2020, 3:03 am
” – Lynn Jokela [read post]
11 Dec 2020, 3:03 am
The topics include: – Annual Season Items – SEC Simplifies Private Offering Exemptions – SEC Overhauls Regulation S-K Financial Disclosures – Lynn Jokela [read post]
14 Jan 2020, 3:02 am
Here are some of the considerations, check out the complete 12-page memo for more: – As of year end, of the 91 S&P 500 companies that filed a Form 10-K since the MD&A changes went into effect last April, 57% discussed 3 years of financial information rather than omitting discussion of the earliest of the 3 years from the MD&A – Whether discussing 3 years or only 2 in the MD&A, companies should remember to review discussion of the earlier years to determine whether… [read post]
10 Dec 2020, 3:03 am
” – Lynn Jokela [read post]
10 Jun 2020, 3:03 am
It’s a 60-page report so it’s chalk full of data, here’s some high-level data points: – Median hotline/incident reports per 100 employees remained steady at 1.4 – but 19% received 5 or more reports per 100 employees – Case closure time increased from 40 to 45 days, a 13% increase – the report says best practice average case closure time should be 30-32 days – about 20% of customers take 100 days or more to close cases – Extended time to… [read post]
7 Oct 2020, 3:03 am
– Lynn Jokela [read post]
4 May 2021, 3:03 am
– Lynn Jokela [read post]
26 Oct 2020, 3:03 am
– Lynn Jokela [read post]
1 Mar 2021, 3:03 am
The issue includes articles on: – The Impact of COVID-19: Our Model CD&A Disclosure – Recent Case Tests Attorney-Client Privilege for Law Firm Assisted Internal Assessments – Deferred Compensation Plan Funded by a Rabbi Trust but Participants are Shut Out by Company and 409A – Officer and Director Indemnification Provisions May Need Review – Lynn Jokela [read post]
26 Jun 2020, 3:03 am
– Lynn Jokela [read post]
21 Feb 2020, 3:03 am
A Brave New World for Confidential Treatment: Asking for Forgiveness Instead of Permission – A New Streamlined Confidential Treatment Process Dawns – Self-Executing Rules – Staff Review of Exhibits – New Streamlined Extension Confidential Treatment Request Procedures – Enter the Supremes: The Impact of Argus Leader – The SEC’s New Confidential Treatment Request Guidance – Lynn Jokela [read post]
17 Apr 2020, 3:03 am
Some basic stats cited in the blog include: Compared to firms with all-male boards, firms with female directors announced high-severity product recalls 28 days sooner The number of women on boards also impacted high-severity recall outcomes – only boards that had at least 2 female directors improved timeliness of severe product recalls and when there were 3, recall decisions moved along even more quickly For low severity recalls – where executives have greater discretion, boards… [read post]
29 Dec 2020, 3:03 am
– Lynn Jokela [read post]
27 May 2020, 3:03 am
– Lynn Jokela [read post]
6 Oct 2020, 3:03 am
The topics include: – SEC Engages in a Flurry of Rulemaking – Regulation FD Turns 20: Our Take – Something to Look Forward to in 2021: Less Non-Issuer Financial Information – Lynn Jokela [read post]
29 May 2020, 3:03 am
– Lynn Jokela [read post]
11 Feb 2021, 3:03 am
– Lynn Jokela [read post]
